DR. BUNMI FEMI-OYEKAN

She is responsible for leading and providing strategic direction and oversight to the Country’s regulatory teams, thus ensuring the development and execution of regulatory strategies and plans to meet business objectives.

 

Bunmi has over 30 years of experience in the pharmaceutical industry in Sales & mostly Regulatory Affairs (RA). She is a principled individual, passionate about integrity and business ethics, and a spirited team player.

 

She joined Pfizer in 1992 as a Medical Sales Representative and was appointed Regulatory Affairs Manager for Ghana and Nigeria in 1999.

 

In 2005, she was appointed as an Associate Director, Regulatory, Safety, and Quality to cover East, West, and Central Africa and her responsibilities have since increased.

 

 

She is a member of the IFPMA African Regulatory Network. She sits on various committees for the development of Regulatory Policies and Guidelines to support regulatory systems strengthening in partnership with local trade associations and other stakeholders.

 

Bunmi holds a bachelor’s degree in Pharmacy and an MBA from Obafemi Awolowo University, Ile-Ife, Nigeria.

 

She is passionate about developing people, building effective teams, and conflict management.a

DR. SARA OMAYA AGAK

Sara is currently the Operations Director and Company Pharmacist for Laborex Kenya Ltd. and

Trade, Policy and Regulatory (TPR) Committee Chair for Kenya Association of Pharmaceutical Industry (KAPI).

She is currently pursuing a Master’s in Business Administration and a Master’s in Health Systems Management.

Her interests include personal and professional coaching, mentoring and training, music, books, sports and travel.

DR. HEBA NABIL

She graduated in the Faculty of Pharmacy Cairo University then started her career in the academic field as a teaching assistant up to senior supervisor in pharmaceutical technology department, Faculty of Pharmacy, Misr International University (MIU).

 

After that she moved to the regulatory affairs field where she joined the Registration General Directorate in the Central Administration for Pharmaceutical Affairs (CAPA), Ministry of Health and Population of Egypt. she worked as the Rapporteur of The Technical Committee for Drug Control then she became the Head of Human Pharmaceutical Drug products Registration Directorate before moving to her current position.”

MS. SUSAN LIN

Susan Lin is the Senior Manager: Health Policy Development for Medscheme Holding (Pty) Ltd. She is a qualified pharmacist with a Bachelor of Pharmacy from Rhodes University and has worked extensively in the healthcare industry.  She has spent the majority of her career in health risk management / managed care.

Susan began her career serving as a dispensing pharmacist in public as well as private sector but later progressed to the Managed Care industry where she managed several portfolios. Her positions included the Executive Manager: Medicines Risk & Electronic Benefit Management and Specialist: Business Modelling & Coordination.

Her notable achievements was on the public and private partnership initiatives in enabling access to care. She consulted for a number of segments within the healthcare industry whereby she facilitated the streamlining of access to primary healthcare and development of technologies to support maternal and child care.

Currently, Susan is heading up the Health Policy Unit where she is responsible for the development of strategies for enabling access to pharmaceutical, technological and medical procedures. One of her ambitions is finding sustainable solutions in building reimbursement models to facilitate the funding of specialised medicines in South Africa.

MR. MITESH PATEL

He has more than 7 years of consulting experience within a variety of industries including, Financial Services, Energy and Resources and Life Sciences and Health Care. Prior to joining Deloitte, Mitesh gained 4 years of clinical experience as a Physiotherapist. His recent focus areas have been Data Strategy, Data Management, Data Privacy and Insights Driven Organisation.

MR. KIRAN BAGTATEE

Kiran currently heads up a cross functional data privacy team for Deloitte Africa and operates in the Risk Advisory Analytics and Cyber Security team. He has more almost 13 years of experience within the consulting industry across banking, insurance, mining, pharmaceuticals and telecommunications.

 

He has a strong focus in the Data Management and Privacy arena relating to Data Governance, Data Quality and the Protection of Personal Information Act (POPIA) with practical implementation of methodologies.

MR. SANTOSH BALBHADRA TRIVEDI

Santosh Balbhadra Trivedi has a Bachelor of Engineering (Chemical) degree from G H Patel College of Engineering and Technology, Vallabh Vidyanagar, Gujarat, India, where he studied from 1998 to 2002. He has almost 20 years of overall experience and has worked in the Pharma & Life Sciences industry vertical for over 12 years in various roles from a Developer to Business Analyst, Product Owner, Serialization and Track & Trace expert, etc.

 

His current role since Feb-2022 is with Honeywell as the Senior Product Manager – Track & Trace facilitating governments/customers implementing Serialization and Track & Trace solutions to adhere to/implement the legal regulation requirements and/or to implement the value added solutions to improvise the supply chain visibility and integrity.

DR. CLARISSE KAUL-CLAMOUNGOU

S/Directrice de l’Homologation des Médicaments et des Autres Produits Pharmaceutiques – AIRP

Membre de la Commission Nationale du Médicament et des autres Produits Pharmaceutiques (CNMPP) représentant l’AIRP

Membre du comité des experts pour l’évaluation technique des demandes d’homologation

Pharmacien inspecteur assermenté au sein de l’AIRP depuis Juin 2022

Experte en Affaires règlementaires avec plus de 15 ans d’expérience dans l’Industrie Pharmaceutique

Membre fondateur de l’ARAF (Association des Règlementaires de l’Afrique Francophone) créé en 2009

Ancien membre des GTT organisés par le LEEM.

MR. ASHIFI GOGO

Ashifi founded Sproxil® in 2009 and currently serves as the company’s Chief Executive Officer. Under his leadership, Sproxil developed its award-winning solutions that have been used on over 2.5 billion product units available to consumers in 6 countries to verify the authenticity of their products and earn instant rewards for their loyalty.

In 2015, Ashifi was named to Fortune’s 40 under 40 list. He was awarded the Social Entrepreneur of the Year award in 2014 by the Schwab Foundation and joined the Fast Company Most Creative People in Business 1000 community. In 2013, Sproxil was named the world’s most innovative company in health care by Fast Company, and #7 most innovative worldwide, beating 99 of the Fortune 100 companies. Most recently, he has been picked as a finalist for the 2020 Global Business Hall of Fame presented by JA Worldwide.

Ashifi served on the World Economic Forum’s Global Agenda Council on Social Innovation and on the Meta-Council on the Illicit Economy. He holds a US Patent and earned a Ph.D. in Engineering from Dartmouth College, where he delivered the 2020 alumni remarks at Investiture. Ashifi holds a B.A. in Mathematics and Physics from Whitman College. He was Whitman’s 2018 commencement speaker and received an honorary doctorate. He is Dartmouth’s first-ever Ph.D. Innovation Fellow and teaches an executive seminar and a course in New Business Ventures Technology Management at Columbia University.

Ashifi volunteers for the Whitman College President’s Advisory Board and the Board of Advisors at Dartmouth’s Thayer School of Engineering.

 

DR. CHOUROUK BENDHIA

Dr. Chourouk Bendhia is Regional regulatory portfolio optimization executive for Emerging Markets at GSK.

 

She holds a Pharm.D certificate with pharmaceutical industry background and regulatory affairs expertise at national (Tunisia) and international level.